Literature DB >> 33327749

Lysolipids in Vascular Development, Biology, and Disease.

Eric Engelbrecht1, Calum A MacRae2, Timothy Hla1.   

Abstract

Membrane phospholipid metabolism forms lysophospholipids, which possess unique biochemical and biophysical properties that influence membrane structure and dynamics. However, lysophospholipids also function as ligands for G-protein-coupled receptors that influence embryonic development, postnatal physiology, and disease. The 2 most well-studied species-lysophosphatidic acid and S1P (sphingosine 1-phosphate)-are particularly relevant to vascular development, physiology, and cardiovascular diseases. This review summarizes the role of lysophosphatidic acid and S1P in vascular developmental processes, endothelial cell biology, and their roles in cardiovascular disease processes. In addition, we also point out the apparent connections between lysophospholipid biology and the Wnt (int/wingless family) pathway, an evolutionarily conserved fundamental developmental signaling system. The discovery that components of the lysophospholipid signaling system are key genetic determinants of cardiovascular disease has warranted current and future research in this field. As pharmacological approaches to modulate lysophospholipid signaling have entered the clinical sphere, new findings in this field promise to influence novel therapeutic strategies in cardiovascular diseases.

Entities:  

Keywords:  cardiovascular diseases; embryonic development; endothelial cells; lysophospholipids; sphingosine

Mesh:

Substances:

Year:  2020        PMID: 33327749      PMCID: PMC8105276          DOI: 10.1161/ATVBAHA.120.305565

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  210 in total

1.  Lysophosphatidic acid activates nuclear factor kappa B and induces proinflammatory gene expression in endothelial cells.

Authors:  A Palmetshofer; S C Robson; V Nehls
Journal:  Thromb Haemost       Date:  1999-11       Impact factor: 5.249

2.  Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease.

Authors:  Katherine J E Sattler; Sehriban Elbasan; Petra Keul; Miriam Elter-Schulz; Constantin Bode; Markus H Gräler; Martina Bröcker-Preuss; Thomas Budde; Raimund Erbel; Gerd Heusch; Bodo Levkau
Journal:  Basic Res Cardiol       Date:  2010-07-21       Impact factor: 17.165

3.  Sphingosine 1-Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex-Induced Vascular Injury.

Authors:  Nathalie Burg; Steven Swendeman; Stefan Worgall; Timothy Hla; Jane E Salmon
Journal:  Arthritis Rheumatol       Date:  2018-11       Impact factor: 10.995

4.  WNT-inflammasome signaling mediates NOD2-induced development of acute arthritis in mice.

Authors:  Vikas Singh; Sahana Holla; Subbaraya G Ramachandra; Kithiganahalli Narayanaswamy Balaji
Journal:  J Immunol       Date:  2015-02-25       Impact factor: 5.422

5.  Endothelial miR-17∼92 cluster negatively regulates arteriogenesis via miRNA-19 repression of WNT signaling.

Authors:  Shira Landskroner-Eiger; Cong Qiu; Paola Perrotta; Mauro Siragusa; Monica Y Lee; Victoria Ulrich; Amelia K Luciano; Zhen W Zhuang; Federico Corti; Michael Simons; Rusty L Montgomery; Dianqing Wu; Jun Yu; William C Sessa
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-28       Impact factor: 11.205

6.  A regulatory microRNA network controls endothelial cell phenotypic switch during sprouting angiogenesis.

Authors:  Federico Bussolino; Alessio Noghero; Stefania Rosano; Davide Corà; Sushant Parab; Serena Zaffuto; Claudio Isella; Roberta Porporato; Roxana Maria Hoza; Raffaele A Calogero; Chiara Riganti
Journal:  Elife       Date:  2020-01-24       Impact factor: 8.140

Review 7.  Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function.

Authors:  Montserrat Serra; Julie D Saba
Journal:  Adv Enzyme Regul       Date:  2009-11-13

8.  miR-133b, a microRNA targeting S1PR1, suppresses nasopharyngeal carcinoma cell proliferation.

Authors:  Nan Cheng; Guang-Hui Wang
Journal:  Exp Ther Med       Date:  2016-02-01       Impact factor: 2.447

Review 9.  Sphingosine 1-phosphate: Lipid signaling in pathology and therapy.

Authors:  Andreane Cartier; Timothy Hla
Journal:  Science       Date:  2019-10-18       Impact factor: 47.728

10.  A molecular atlas of cell types and zonation in the brain vasculature.

Authors:  Michael Vanlandewijck; Liqun He; Maarja Andaloussi Mäe; Johanna Andrae; Koji Ando; Francesca Del Gaudio; Khayrun Nahar; Thibaud Lebouvier; Bàrbara Laviña; Leonor Gouveia; Ying Sun; Elisabeth Raschperger; Markus Räsänen; Yvette Zarb; Naoki Mochizuki; Annika Keller; Urban Lendahl; Christer Betsholtz
Journal:  Nature       Date:  2018-02-14       Impact factor: 49.962

View more
  5 in total

1.  Sphingosine 1-Phosphate Metabolism and Signaling.

Authors:  Yan Hu; Kezhi Dai
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  Sphingosine 1-phosphate receptor-targeted therapeutics in rheumatic diseases.

Authors:  Nathalie Burg; Jane E Salmon; Timothy Hla
Journal:  Nat Rev Rheumatol       Date:  2022-05-04       Impact factor: 20.543

3.  Comparative Metabolomics and Lipidomics of Four Juvenoids Application to Scylla paramamosain Hepatopancreas: Implications of Lipid Metabolism During Ovarian Maturation.

Authors:  Yin Fu; Fengying Zhang; Chunyan Ma; Wei Wang; Zhiqiang Liu; Wei Chen; Ming Zhao; Lingbo Ma
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-27       Impact factor: 6.055

Review 4.  Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities.

Authors:  Jiaqi Liu; Qing Xiao; Jiani Xiao; Chenxi Niu; Yuanyuan Li; Xiaojun Zhang; Zhengwei Zhou; Guang Shu; Gang Yin
Journal:  Signal Transduct Target Ther       Date:  2022-01-03

5.  Selective sphingosine-1-phosphate receptor 1 modulator attenuates blood-brain barrier disruption following traumatic brain injury by inhibiting vesicular transcytosis.

Authors:  Yuan Zhang; Lin Wang; Qiuling Pan; Xiaomin Yang; Yunchuan Cao; Jin Yan; Yingwen Wang; Yihao Tao; Runjin Fan; Xiaochuan Sun; Lin Li
Journal:  Fluids Barriers CNS       Date:  2022-07-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.